Medical Science Liaison (Haematology/Oncology)
ΠΡΡΡ & Π‘ΠΎΠΏΡΠΎΠ²ΠΎΠ΄
ΠΠ»Ρ ΠΌΡΡΡΠ° Ρ ΡΡΠΎΠΉ Π²Π°ΠΊΠ°Π½ΡΠΈΠ΅ΠΉ Π½ΡΠΆΠ΅Π½ Plus
ΠΠΏΠΈΡΠ°Π½ΠΈΠ΅ Π²Π°ΠΊΠ°Π½ΡΠΈΠΈ
Location: Reading, Berkshire, United Kingdom; London or the South of England preferred, with national UK coverage. Hybrid working with regular NHS and scientific engagement.
Company
provides clinical research services, commercial insights, and healthcare intelligence for the life sciences and healthcare industries.
What you will do
- Deliver non-promotional, disease-state scientific exchange in Chronic Myeloid Leukaemia.
- Build and maintain relationships with UK key opinion leaders across major haematology centres.
- Support pre-launch medical readiness, scientific platforms, and launch activities.
- Capture and communicate medical insights to inform evidence strategy and decision-making.
- Support compliant real-world evidence, investigator-sponsored studies, advisory boards, congresses, and scientific meetings.
- Act as a medical subject-matter expert for internal stakeholders after launch.
Requirements
- Advanced life-science degree such as PhD, PharmD, MD, MSc, or equivalent.
- At least 2β3+ years of UK MSL experience.
- Background in oncology and/or haematology.
- Strong knowledge of the ABPI Code and UK compliance requirements.
- Legal right to work in the United Kingdom is required; valid UK work authorisation must be held when applying.
- Visa sponsorship is not offered.
Nice to have
- Chronic Myeloid Leukaemia experience.
- Early-phase launch exposure.
Culture & Benefits
- Field-based medical affairs role with hybrid working.
- High-visibility involvement in a UK product launch.
- Collaboration with NHS haematology stakeholders and internal cross-functional teams.
- Opportunity to contribute to evidence generation and launch readiness in a fast-moving medical affairs environment.
ΠΡΠ΄ΡΡΠ΅ ΠΎΡΡΠΎΡΠΎΠΆΠ½Ρ: Π΅ΡΠ»ΠΈ ΡΠ°Π±ΠΎΡΠΎΠ΄Π°ΡΠ΅Π»Ρ ΠΏΡΠΎΡΠΈΡ Π²ΠΎΠΉΡΠΈ Π² ΠΈΡ ΡΠΈΡΡΠ΅ΠΌΡ, ΠΈΡΠΏΠΎΠ»ΡΠ·ΡΡ iCloud/Google, ΠΏΡΠΈΡΠ»Π°ΡΡ ΠΊΠΎΠ΄/ΠΏΠ°ΡΠΎΠ»Ρ, Π·Π°ΠΏΡΡΡΠΈΡΡ ΠΊΠΎΠ΄/ΠΠ, Π½Π΅ Π΄Π΅Π»Π°ΠΉΡΠ΅ ΡΡΠΎΠ³ΠΎ - ΡΡΠΎ ΠΌΠΎΡΠ΅Π½Π½ΠΈΠΊΠΈ. ΠΠ±ΡΠ·Π°ΡΠ΅Π»ΡΠ½ΠΎ ΠΆΠΌΠΈΡΠ΅ "ΠΠΎΠΆΠ°Π»ΠΎΠ²Π°ΡΡΡΡ" ΠΈΠ»ΠΈ ΠΏΠΈΡΠΈΡΠ΅ Π² ΠΏΠΎΠ΄Π΄Π΅ΡΠΆΠΊΡ. ΠΠΎΠ΄ΡΠΎΠ±Π½Π΅Π΅ Π² Π³Π°ΠΉΠ΄Π΅ β